Peroxitech LLC
Philadelphia, PA · Biotech · Private
PIP-2, a nine amino-acid peptide that blocks Peroxiredoxin 6 phospholipase A2 activity to reduce reactive oxygen species production in stored donor lungs
- Grants
- $900K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Evaluation of a peptide that inhibits the activation of NOX2 and the generation of reactive oxygen species in protection against acute lung injury | $299,866 | |
| Federal grant | Department of Health and Human Services · Phase I · An additive solution to expand the lung transplant organ pool | $299,931 | |
| Federal grant | Department of Health and Human Services · Phase I · An additive solution to expand the lung transplant organ pool | $299,931 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1716 | Metallomix, Inc | — | $2.1M |
| 1717 | Mission Therapeutics | — | — |
| 1718 | Curve Therapeutics | — | — |
| 1719 | Peroxitech LLC | — | — |
| 1720 | SAMBA BIOLOGICS INC. | — | — |
| 1721 | AAVOGEN INC | — | — |
| 1722 | Emergo Therapeutics, Inc. | — | $4.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.